Celebrating the Digital Age
Digital technologies could transform healthcare, including drug discovery, development, clinical trials and patient empowerment.
Sophie Kornowski-Bonnet |
At times, working in the healthcare industry can be very exciting, but also challenging and frustrating. You may have a very exciting drug candidate in development, and yet you won’t be able to get it to patients for a very long time. One of the big focuses for Roche right now is personalized healthcare – many people in the industry, including myself, are very excited by this concept and approach. Personalized healthcare is about matching treatments to patients’ individual needs, often driven by their genetic profiles – and we are seeing many advances in personalized cancer therapies in particular.
Personalized healthcare goes hand in hand with digital technologies – for example, machine learning and other advanced analytic techniques can enhance drug discovery and development by identifying new drug targets and effective surrogate markers. Research and development at Roche focuses on the therapeutic areas of oncology, ophthalmology, asthma, rheumatoid arthritis, neuroscience, inflammatory bowel disease and infections – and digital technology that allows us to deeply explore the science of disease and its genetic basis are incredibly important. As one example, we are using smart technology and genomic analyses to identify new antibiotics targeting gram-negative bacteria.
Enjoy our FREE content!
Log in or register to read this article in full and gain access to The Translational Scientist’s entire content archive. It’s FREE and always will be!